Section

US-China Decoupling Poses Supply Chain Risks for Drug Companies

By wsj - 8 months ago
A proposed bill in Congress targets Chinese biotech businesses that play an important role in developing drugs.

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.